Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR.

Lei W, Wang ZL, Feng HJ, Lin XD, Li CZ, Fan D.

Int J Oncol. 2018 Jul 11. doi: 10.3892/ijo.2018.4478. [Epub ahead of print]

PMID:
30015836
2.

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.

Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.

PMID:
28991227
3.

Hu antigen R (HuR) multimerization contributes to glioma disease progression.

Filippova N, Yang X, Ananthan S, Sorochinsky A, Hackney JR, Gentry Z, Bae S, King P, Nabors LB.

J Biol Chem. 2017 Oct 13;292(41):16999-17010. doi: 10.1074/jbc.M117.797878. Epub 2017 Aug 8.

PMID:
28790173
4.

MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.

Lo Dico A, Costa V, Martelli C, Diceglie C, Rajata F, Rizzo A, Mancone C, Tripodi M, Ottobrini L, Alessandro R, Conigliaro A.

Theranostics. 2016 May 8;6(8):1105-18. doi: 10.7150/thno.14700. eCollection 2016.

5.

MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.

Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T.

Oncotarget. 2016 Jul 5;7(27):41505-41526. doi: 10.18632/oncotarget.9214.

6.

PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.

Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO.

Int J Cancer. 2016 Jul 1;139(1):99-111. doi: 10.1002/ijc.30041. Epub 2016 Mar 2.

7.

Growth factor dependent regulation of centrosome function and genomic instability by HuR.

Filippova N, Yang X, Nabors LB.

Biomolecules. 2015 Mar 20;5(1):263-81. doi: 10.3390/biom5010263.

8.

Gene expression analyses to explore the biomarkers and therapeutic targets for gliomas.

Wang L, Wei B, Hu G, Wang L, Jin Y, Sun Z.

Neurol Sci. 2015 Mar;36(3):403-9. doi: 10.1007/s10072-014-1985-0. Epub 2014 Oct 28. Retraction in: Neurol Sci. 2015 Oct;36(10):1981.

PMID:
25348135
9.

Pathway and network analysis in glioma with the partial least squares method.

Gu WT, Gu SX, Shou JJ.

Asian Pac J Cancer Prev. 2014;15(7):3145-9.

10.

Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.

Suswam EA, Shacka JJ, Walker K, Lu L, Li X, Si Y, Zhang X, Zheng L, Nabors LB, Cao H, King PH.

J Neurooncol. 2013 Jun;113(2):195-205. doi: 10.1007/s11060-013-1112-8. Epub 2013 Mar 25.

11.

Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function.

Filippova N, Yang X, King P, Nabors LB.

J Biol Chem. 2012 Sep 14;287(38):32277-87. doi: 10.1074/jbc.M112.353912. Epub 2012 Jul 24.

12.

mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.

Bolognani F, Gallani AI, Sokol L, Baskin DS, Meisner-Kober N.

J Neurooncol. 2012 Feb;106(3):531-42. doi: 10.1007/s11060-011-0707-1. Epub 2011 Sep 21.

PMID:
21935689
13.

The RNA-binding protein HuR promotes glioma growth and treatment resistance.

Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH, Wheeler C, Nabors LB.

Mol Cancer Res. 2011 May;9(5):648-59. doi: 10.1158/1541-7786.MCR-10-0325. Epub 2011 Apr 15.

14.

IL-1β potently stabilizes IL-6 mRNA in human astrocytes.

Spooren A, Mestdagh P, Rondou P, Kolmus K, Haegeman G, Gerlo S.

Biochem Pharmacol. 2011 Apr 15;81(8):1004-15. doi: 10.1016/j.bcp.2011.01.019. Epub 2011 Feb 12.

PMID:
21300032
15.

Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.

Lu L, Wang S, Zheng L, Li X, Suswam EA, Zhang X, Wheeler CG, Nabors LB, Filippova N, King PH.

J Biol Chem. 2009 Dec 4;284(49):33989-98. doi: 10.1074/jbc.M109.067918. Epub 2009 Oct 5.

16.

Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, King PH.

Cancer Res. 2008 Feb 1;68(3):674-82. doi: 10.1158/0008-5472.CAN-07-2751.

17.

Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR.

Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH.

Cancer Res. 2003 Jul 15;63(14):4181-7.

18.

Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: role of potential post-transcriptional degradation factors.

Kirigiti P, Bai Y, Yang YF, Li X, Li B, Brewer G, Machida CA.

Mol Pharmacol. 2001 Dec;60(6):1308-24.

Supplemental Content

Loading ...
Support Center